208 related articles for article (PubMed ID: 29350833)
1. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.
Palankar R; Kohler TP; Krauel K; Wesche J; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2018 Jun; 16(6):1187-1197. PubMed ID: 29350833
[TBL] [Abstract][Full Text] [Related]
2. Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodies.
Wolff M; Handtke S; Palankar R; Wesche J; Kohler TP; Kohler C; Gruel Y; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2020 Jun; 18(6):1459-1468. PubMed ID: 32237268
[TBL] [Abstract][Full Text] [Related]
3. Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis.
Arman M; Krauel K
J Thromb Haemost; 2015 Jun; 13(6):893-908. PubMed ID: 25900780
[TBL] [Abstract][Full Text] [Related]
4. Bacteria exploit platelets.
Naik UP
Blood; 2014 May; 123(20):3067-8. PubMed ID: 24832941
[TBL] [Abstract][Full Text] [Related]
5. Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4.
Arman M; Krauel K; Tilley DO; Weber C; Cox D; Greinacher A; Kerrigan SW; Watson SP
Blood; 2014 May; 123(20):3166-74. PubMed ID: 24642751
[TBL] [Abstract][Full Text] [Related]
6. Human platelets efficiently kill IgG-opsonized E. coli.
Riaz AH; Tasma BE; Woodman ME; Wooten RM; Worth RG
FEMS Immunol Med Microbiol; 2012 Jun; 65(1):78-83. PubMed ID: 22340259
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeleton Dependent Mobility Dynamics of FcγRIIA Facilitates Platelet Haptotaxis and Capture of Opsonized Bacteria.
Palankar R; Sachs L; Wesche J; Greinacher A
Cells; 2022 May; 11(10):. PubMed ID: 35626650
[TBL] [Abstract][Full Text] [Related]
8. Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3.
Watson CN; Kerrigan SW; Cox D; Henderson IR; Watson SP; Arman M
Platelets; 2016 Sep; 27(6):535-40. PubMed ID: 27025455
[TBL] [Abstract][Full Text] [Related]
9. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
11. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.
Nguyen TH; Medvedev N; Delcea M; Greinacher A
Nat Commun; 2017 May; 8():14945. PubMed ID: 28530237
[TBL] [Abstract][Full Text] [Related]
12. Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.
Naylor-Adamson L; Chacko AR; Booth Z; Caserta S; Jarvis J; Khan S; Hart SP; Rivero F; Allsup DJ; Arman M
Front Immunol; 2021; 12():766272. PubMed ID: 34912339
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor.
Fitzgerald JR; Loughman A; Keane F; Brennan M; Knobel M; Higgins J; Visai L; Speziale P; Cox D; Foster TJ
Mol Microbiol; 2006 Jan; 59(1):212-30. PubMed ID: 16359330
[TBL] [Abstract][Full Text] [Related]
14. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia.
Krauel K; Pötschke C; Weber C; Kessler W; Fürll B; Ittermann T; Maier S; Hammerschmidt S; Bröker BM; Greinacher A
Blood; 2011 Jan; 117(4):1370-8. PubMed ID: 20959601
[TBL] [Abstract][Full Text] [Related]
15. Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin αIIbβ3 and Lyn Kinase.
Zhi H; Dai J; Liu J; Zhu J; Newman DK; Gao C; Newman PJ
PLoS One; 2015; 10(8):e0135738. PubMed ID: 26291522
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis and intracellular killing of serum-opsonized Staphylococcus aureus by mouse fibroblasts expressing human Fcgamma receptor type IIa (CD32).
Nibbering PH; Broug-Holub E; Bezemer AC; Jansen R; van de Winkel JG; Geertsma MF
Front Biosci; 1996 Apr; 1():a25-33. PubMed ID: 9159191
[TBL] [Abstract][Full Text] [Related]
17. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
18. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura.
Kuwana M; Okazaki Y; Ikeda Y
J Thromb Haemost; 2009 Feb; 7(2):322-9. PubMed ID: 18826388
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
Newman PM; Chong BH
Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
[TBL] [Abstract][Full Text] [Related]
20. An α
Kuo YJ; Chen YR; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2017 Nov; 15(11):2230-2244. PubMed ID: 28815933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
